Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in:

01.02.2014 | original article

Atrial electromechanical delay in type 2 diabetes mellitus

verfasst von: Ahmet Akyel, MD, Fatih Öksüz, MD, Muhammed Karadeniz, MD, Mikail Yarlıoğlueş, MD, Gökhan Ergün, MD, Tayyar Cankurt, MD, Ahmet Yozgat, MD, Müge Keskin Arıel, MD, Yalçın Aral, MD, Sani Namık Murat, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2014

Einloggen, um Zugang zu erhalten

Summary

Background

Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Increased atrial electromechanical delay (AEMD) is known to be a precursor of AF. In this study, we aimed to investigate AEMD in patients with type 2 DM.

Methods

A total of 110 participants were recruited to the present study. Of them, 70 were diabetic patients, and 40 were healthy control subjects. Basal characteristics were recorded and transthoracic echocardiography was performed for all study participants.

Results

Basal characteristics were similar between the two groups. There was significant intra-atrial and interatrial electromechanical delay in the diabetic group compared with the control group. In the correlation analysis, no correlation existed between AEMD and hemoglobin A1C or fasting plasma glucose levels.

Conclusion

In the present study, we showed that there was significant AEMD in patients with type 2 DM compared with healthy control subjects. Increased AEMD might be an early marker of AF in this patient subset. To clear this hypothesis, further studies are needed.
Vorheriger Artikel Effects of migration background on weight status and motor performance of preschool children
Nächster Artikel Insulin resistance may contribute to vascular dysfunction in patients with chronic obstructive pulmonary disease
Literatur
1.
Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994 Mar 16;271(11):840–4.PubMedCrossRef
2.
Camm AJ, Lip GY, De Caterina R, et al. ESC Committee for Practice Guidelines-CPG; Document Reviewers. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association. Europace. 2012 Oct;14(10):1385–413.PubMedCrossRef
3.
Cui QQ, Zhang W, Wang H, et al. Assessment of atrial electromechanical coupling and influential factors in nonrheumatic paroxysmal atrial fibrillation. Clin Cardiol. 2008 Feb;31(2):74–8.PubMedCrossRef
4.
Deniz A, Sahiner L, Aytemir K, Kaya B, Kabakci G, Tokgozoglu L, Oto A. Tissue Doppler echocardiography can be a useful technique to evaluate atrial conduction time. Cardiol J. 2012;19(5):487–93.PubMedCrossRef
5.
American Diabetes Association.  Executive summary: standards of medical care in diabetes—2011. Diabetes Care. 2011 Jan;34 Suppl 1:S11–61.CrossRef
6.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285:2486–97.CrossRef
7.
Aksnes TA, Schmieder RE, Kjeldsen SE, Ghani S, Hua TA, Julius S. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol. 2008 Mar 1;101(5):634–8.PubMedCrossRef
8.
Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001 May 9;285(18):2370–5.PubMedCrossRef
9.
Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995 May;98(5):476–84.PubMedCrossRef
10.
Klem I, Wehinger C, Schneider B, Hartl E, Finsterer J, Stöllberger C. Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up. Diabetes Metab Res Rev. 2003 Jul-Aug;19(4):320–8.PubMedCrossRef
11.
Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005 Dec 7;105(3):315–8.PubMedCrossRef
12.
Kato T, Yamashita T, Sekiguchi A, et al. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol. 2006 Aug;17(8):890–4.PubMedCrossRef
13.
Fu H, Liu C, Li J, Zhou C, Cheng L, Liu T, Li G. Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits. Cardiol J. 2013;20(1):59–67.PubMedCrossRef
14.
Chao TF, Suenari K, Chang SL, et al. Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose. Am J Cardiol. 2010 Dec 1;106(11):1615–20.PubMedCrossRef
15.
Pytkowski M, Jankowska A, Maciag A, et al. Paroxysmal atrial fibrillation is associated with increased intra-atrial conduction delay. Europace. 2008 Dec;10(12):1415–20.PubMedCrossRef
16.
De Vos CB, Weijs B, Crijns HJ, et al. Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation. Heart. 2009 May;95(10):835–40.PubMedCrossRef
17.
Chao TF, Sung SH, Wang KL, et al. Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation. Heart. 2011;97:225–30.PubMedCrossRef
18.
Kurt M, Tanboğa IH, Karakas¸ MF, Büyükkaya E, Akcay AB, Sen N, Bilen E. The relationship between atrial electromechanical delay and P-wave dispersion with the presence and severity of metabolic syndrome. Turk Kardiyol Dern Ars. 2012 Dec;40(8):663–70.PubMedCrossRef
19.
Ayhan S, Ozturk S, Alcelik A, et al. Atrial conduction time and atrial mechanical function in patients with impaired fasting glucose. J Interv Card Electrophysiol. 2012 Dec;35(3):247–52.PubMedCrossRef
20.
Acar G, Akcay A, Sokmen A, et al. Assessment of atrial electromechanical delay, diastolic functions, and left atrial mechanical functions in patients with type 1 diabetes mellitus. J Am Soc Echocardiogr. 2009 Jun;22(6):732–8.PubMedCrossRef
21.
Hung CL, Chao TF, Lai YH, et al. The relationship among atrium electromechanical interval, insulin resistance, and metabolic syndrome. Can J Cardiol. 2013 Mar 13. doi:10.1016/j.cjca.2013.01.001.
Metadaten
Titel
Atrial electromechanical delay in type 2 diabetes mellitus
verfasst von
Ahmet Akyel, MD
Fatih Öksüz, MD
Muhammed Karadeniz, MD
Mikail Yarlıoğlueş, MD
Gökhan Ergün, MD
Tayyar Cankurt, MD
Ahmet Yozgat, MD
Müge Keskin Arıel, MD
Yalçın Aral, MD
Sani Namık Murat, MD
Publikationsdatum
01.02.2014
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-013-0477-1

Weitere Artikel der Ausgabe 3-4/2014

Giant right coronary artery aneurysm with right ventricle fistula

  • images in clinical medicine

Does tocilizumab contribute to elevation of rheumatoid factor and induction of paradoxical syaloadenitis in rheumatoid arthritis patients?

  • case report

Evaluation of treatment responses and colony-forming progenitor cells in 50 patients with aplastic anemia after immunosuppressive therapy or hematopoietic stem cell transplantation: a single-center experience

  • original article

Insulin resistance may contribute to vascular dysfunction in patients with chronic obstructive pulmonary disease

  • original article

Researcher of the Month

  • MUW researcher of the month

ÖGIM Flip

  • mitteilungen der gesellschaft